Literature DB >> 15877934

Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) -- the spontaneously hypertensive rat (SHR).

Rui D S Prediger1, Fabrício A Pamplona, Daniel Fernandes, Reinaldo N Takahashi.   

Abstract

The spontaneously hypertensive rat (SHR) is generally considered to be a suitable genetic model for the study of attention deficit hyperactivity disorder (ADHD), since it displays hyperactivity, impulsivity, poorly sustained attention, and deficits in learning and memory processes. Converging evidence suggests a primary role of disturbance in the dopaminergic neurotransmission in ADHD patients and in SHR, and in addition, some studies have also demonstrated alterations in adenosinergic neurotransmission in SHR. In the present study, adult female Wistar (WIS) and SHR rats received caffeine (1-10 mg/kg i.p.) 30 min before training, immediately after training, or 30 min before a test session in the spatial version of the Morris water maze. The effect of caffeine administration on WIS and SHR blood pressure was also measured. SHR needed significantly more trials in the training session to acquire the spatial information, but they displayed a similar profile to that of WIS rats in the test session (48 h later), demonstrating a selective deficit in spatial learning. Pre-training administration of caffeine (1-10 mg/kg i.p.) improved this spatial learning deficit in SHR, but did not alter the WIS performance. In contrast, post-training administration of caffeine (3 mg/kg i.p.) did not alter the SHR test performance, but increased memory retention in WIS rats. No dose of caffeine tested altered the mean blood pressure of WIS or SHR. These results demonstrate a selective spatial learning deficit in SHR which can be attenuated by pre-training administration of caffeine. In addition, the present findings indicate that the spatial learning deficit in SHR is not directly related to hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877934     DOI: 10.1017/S1461145705005341

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  27 in total

1.  Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study.

Authors:  Sílvia Oliveira; Ana Paula Ardais; Clarissa Ribeiro Bastos; Marta Gazal; Karen Jansen; Luciano de Mattos Souza; Ricardo Azevedo da Silva; Manuella Pinto Kaster; Diogo Rizzato Lara; Gabriele Ghisleni
Journal:  Purinergic Signal       Date:  2018-12-03       Impact factor: 3.765

Review 2.  Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Authors:  Will C McClatchey; Gail B Mahady; Bradley C Bennett; Laura Shiels; Valentina Savo
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

Review 3.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

4.  Energy drinks and their component modulate attention, memory, and antioxidant defences in rats.

Authors:  M T Costa Valle; N S Couto-Pereira; C Lampert; D M Arcego; A P Toniazzo; R P Limberger; E Dallegrave; C Dalmaz; M D Arbo; M B Leal
Journal:  Eur J Nutr       Date:  2017-08-12       Impact factor: 5.614

5.  Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity.

Authors:  Ibrahim A Alhaider; Abdulaziz M Aleisa; Trinh T Tran; Karem H Alzoubi; Karim A Alkadhi
Journal:  Sleep       Date:  2010-04       Impact factor: 5.849

6.  Chronic caffeine treatment prevents stress-induced LTP impairment: the critical role of phosphorylated CaMKII and BDNF.

Authors:  K H Alzoubi; M Srivareerat; A M Aleisa; K A Alkadhi
Journal:  J Mol Neurosci       Date:  2012-06-16       Impact factor: 3.444

7.  Differential Behavioral and Biochemical Responses to Caffeine in Male and Female Rats from a Validated Model of Attention Deficit and Hyperactivity Disorder.

Authors:  Fernanda Nunes; Daniela Pochmann; Amanda Staldoni Almeida; Daniela Melo Marques; Lisiane de Oliveira Porciúncula
Journal:  Mol Neurobiol       Date:  2018-03-20       Impact factor: 5.590

8.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

9.  Medial temporal lobe functioning and structure in the spontaneously hypertensive rat: comparison with Wistar-Kyoto normotensive and Wistar-Kyoto hypertensive strains.

Authors:  Audrey M Wells; Amy C Janes; Xiaoxu Liu; Christian F Deschepper; Marc J Kaufman; Kathleen M Kantak
Journal:  Hippocampus       Date:  2010-06       Impact factor: 3.899

Review 10.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.